{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:48:22Z","timestamp":1772664502310,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clbc.2017.12.005","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T13:55:23Z","timestamp":1513000523000},"page":"e695-e698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic"],"prefix":"10.1016","volume":"18","author":[{"given":"Yael","family":"Laitman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana Madorsky","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miri","family":"Sklair-Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ady","family":"Yosepovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Barshack-Nakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malka","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osnat","family":"Halshtok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Shalmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gotlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitan","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2017.12.005_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clbc.2017.12.005_bib2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clbc.2017.12.005_bib3","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1245\/s10434-013-3205-1","article-title":"Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort","volume":"20","author":"Greenup","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"suppl 4","key":"10.1016\/j.clbc.2017.12.005_bib4","doi-asserted-by":"crossref","first-page":"iv59","DOI":"10.1093\/annonc\/mdw337.03","article-title":"The impact of reproductive factors and oral contraception on breast cancer risk in women with BRCA mutation or family history of breast cancer","volume":"27","author":"Toss","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2017.12.005_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mgg3.191","article-title":"Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers","volume":"4","author":"Rieder","year":"2015","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.clbc.2017.12.005_bib6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.breast.2014.08.010","article-title":"Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less","volume":"23","author":"Bayraktar","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2017.12.005_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10689-012-9531-9","article-title":"Breast cancer risk factors differ between Asian and white women with BRCA1\/2 mutations","volume":"11","author":"Bruin","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1016\/j.clbc.2017.12.005_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","article-title":"Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations","volume":"51","author":"Brohet","year":"2013","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.clbc.2017.12.005_bib9","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Genetic\/Familial High-Risk Assessment: Breast and Ovarian Version 2.2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Accessed on December 7, 2016."},{"key":"10.1016\/j.clbc.2017.12.005_bib10","unstructured":"American College of Radiology ACR Appropriateness. Available at: https:\/\/acsearch.acr.org\/docs\/70910\/Narrative\/. Accessed on August 21, 2017."},{"key":"10.1016\/j.clbc.2017.12.005_bib11","unstructured":"The American Society of Breast Surgeons Consensus Guideline on Hereditary Genetic Testing for Patients With and Without Breast Cancer. Available at: https:\/\/www.breastsurgeons.org\/new_layout\/about\/statements\/PDF_Statements\/BRCA_Testing.pdf. Accessed on August 21, 2017."},{"key":"10.1016\/j.clbc.2017.12.005_bib12","first-page":"e945","article-title":"Breast cancer screening for high-risk patients of different ages and risk - which modality is most effective?","volume":"8","author":"Wellings","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.clbc.2017.12.005_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/bjc.2016.32","article-title":"Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis","volume":"114","author":"Phi","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2017.12.005_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10549-016-3912-y","article-title":"Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study","volume":"158","author":"Narayan","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.12.005_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/M14-0692","article-title":"Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts","volume":"162","author":"Sprague","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clbc.2017.12.005_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00404-013-3022-6","article-title":"Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers","volume":"289","author":"Bosse","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clbc.2017.12.005_bib17","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cncr.26424","article-title":"Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers","volume":"118","author":"Lowry","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.12.005_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/cncr.27864","article-title":"Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers","volume":"119","author":"Chubiz","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.12.005_bib19","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1002\/cncr.25971","article-title":"Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer","volume":"117","author":"Le-Petross","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.12.005_bib20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","article-title":"Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density","volume":"3","author":"Riedl","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.12.005_bib21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","article-title":"A\u00a0prospective study of breast cancer incidence and stage distribution in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging","volume":"29","author":"Warner","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.12.005_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10549-013-2540-z","article-title":"Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program","volume":"139","author":"M\u00f8ller","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.12.005_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-016-3805-0","article-title":"An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers","volume":"157","author":"Madorsky-Feldman","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.12.005_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10549-015-3340-4","article-title":"Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers","volume":"150","author":"Laitman","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.12.005_bib25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination","volume":"292","author":"Warner","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2017.12.005_bib26","first-page":"549","article-title":"A\u00a0dedicated follow-up clinic for BRCA mutation carriers","volume":"18","author":"Yerushalmi","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.clbc.2017.12.005_bib27","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2017.12.005_bib28","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2017.12.005_bib29","doi-asserted-by":"crossref","first-page":"dju091","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: a systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2017.12.005_bib30","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1530\/ERC-16-0277","article-title":"Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers","volume":"23","author":"Milne","year":"2016","journal-title":"Endocr Relat Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917305591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917305591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:14Z","timestamp":1761513374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820917305591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1526820917305591"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2017.12.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2017.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}